imiquimod has been researched along with mycophenolic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sauder, DN | 1 |
| CostaPinto, L; Grassi, MF; Olavarria, VN; Santiago, MB; Serravalle, K; Travessa, AC | 1 |
| Moore, S; Rady, P; Tyring, S | 1 |
2 review(s) available for imiquimod and mycophenolic acid
| Article | Year |
|---|---|
Mechanism of action and emerging role of immune response modifier therapy in dermatologic conditions.
Topics: Adjuvants, Immunologic; Alefacept; Aminoquinolines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; CD11 Antigens; Dermatitis, Atopic; Glucocorticoids; Humans; Imiquimod; Interferons; Membrane Glycoproteins; Mycophenolic Acid; Psoriasis; Receptors, Cell Surface; Recombinant Fusion Proteins; Skin Diseases; Tacrolimus; Toll-Like Receptors | 2004 |
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
Topics: Acitretin; Cidofovir; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Mycophenolic Acid; Papillomaviridae; Papillomavirus Infections; Vaccines | 2022 |
1 other study(ies) available for imiquimod and mycophenolic acid
| Article | Year |
|---|---|
Giant disseminated condylomatosis in SLE.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Papillomaviridae; Podophyllin; Treatment Outcome; Trichloroacetic Acid | 2012 |